|
Volumn 28, Issue 12, 2006, Pages 942-945
|
Analysis of combinated transcatheter hepatic artery chemoembolization and factors affecting the prognosis in patients with primary hepatic carcinoma
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETALDEHYDE;
ANTINEOPLASTIC AGENT;
ADULT;
AGE;
AGED;
ARTICLE;
CHEMOEMBOLIZATION;
FEMALE;
FOLLOW UP;
HUMAN;
INTRAARTERIAL DRUG ADMINISTRATION;
INTRADERMAL DRUG ADMINISTRATION;
LIVER CELL CARCINOMA;
LIVER RESECTION;
LIVER TUMOR;
MALE;
METHODOLOGY;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PORTAL VEIN;
PROGNOSIS;
PROPORTIONAL HAZARDS MODEL;
STATISTICS;
SURVIVAL;
TUMOR EMBOLISM;
ACETALDEHYDE;
ADULT;
AGE FACTORS;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, HEPATOCELLULAR;
CHEMOEMBOLIZATION, THERAPEUTIC;
COMBINED MODALITY THERAPY;
FEMALE;
FOLLOW-UP STUDIES;
HEPATECTOMY;
HUMANS;
INFUSIONS, INTRA-ARTERIAL;
INJECTIONS, INTRADERMAL;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM CIRCULATING CELLS;
PORTAL VEIN;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
SURVIVAL ANALYSIS;
|
EID: 40749088137
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|